Experimental Pharmacotherapy for COVID-19: The Latest Advances

The coronavirus infectious disease-2019 (COVID-19) has overwhelmed like a shock wave in a completely unprepared world. Despite coronavirus infections were involved in previous epidemic outbreaks, no antiviral agent was developed for specific treatment. As a consequence, since the beginning of this p...

Full description

Saved in:
Bibliographic Details
Published in:Journal of experimental pharmacology 2021, Vol.13, p.1-13
Main Authors: Pagliano, Pasquale, Scarpati, Giuliana, Sellitto, Carmine, Conti, Valeria, Spera, Anna Maria, Ascione, Tiziana, Piazza, Ornella, Filippelli, Amelia
Format: Article
Language:English
Subjects:
Anticoagulants
Antiretroviral drugs
Antiviral agents
Antiviral drugs
ARDS
chloroquine
Coronaviruses
COVID-19
Development and progression
Drug approval
Drug dosages
Drug therapy
Health aspects
heparin
Homeopathy
Hydroxychloroquine
Infection
Marburg virus disease
Materia medica and therapeutics
Monoclonal antibodies
Mortality
remdesivir
Review
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
steroids
Therapeutics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!